₹4.1*
MRP ₹4.5
9% off
₹3.82*
MRP ₹4.5
15% CB
₹0.68 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Product Substitutes
Composition
GLIBENCLAMIDE-2.5MG
Manufacturer/Marketer
Aristo Pharmaceuticals Limited
Consume Type
ORAL
Return Policy
3 Days Returnable
Expires on or after
Apr-24
for this medicine
Drug-Drug Interactions
GlibenclamideNalidixic acid
Severe
GlibenclamideMiconazole
Severe
Drug-Drug Interactions
Login/Sign Up
GlibenclamideNalidixic acid
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Nalidixic acid can affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Nalidixic acid if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Monitoring of blood glucose levels is advised. Do not discontinue any medications without consulting a doctor.
Co-administration of Nalidixic acid can affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Nalidixic acid if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Monitoring of blood glucose levels is advised. Do not discontinue any medications without consulting a doctor.
GlibenclamideMiconazole
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Miconazole with Glybovin 2.5 mg Tablet 10's may increase the blood levels and effects of Glybovin 2.5 mg Tablet 10's leading to low blood glucose levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with miconazole if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
Co-administration of Miconazole with Glybovin 2.5 mg Tablet 10's may increase the blood levels and effects of Glybovin 2.5 mg Tablet 10's leading to low blood glucose levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with miconazole if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
GlibenclamideFluconazole
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Glybovin 2.5 mg Tablet 10's with Fluconazole may cause an increase in the blood levels and effects of Glybovin 2.5 mg Tablet 10's leading to low blood sugar levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Fluconazole if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
Co-administration of Glybovin 2.5 mg Tablet 10's with Fluconazole may cause an increase in the blood levels and effects of Glybovin 2.5 mg Tablet 10's leading to low blood sugar levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Fluconazole if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
GlibenclamideLomefloxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Lomefloxacin may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with lomefloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
Co-administration of Lomefloxacin may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with lomefloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Monitoring of blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
GlibenclamideEnoxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
When Glybovin 2.5 mg Tablet 10's is taken with Enoxacin, it may affect the blood glucose levels which may leads to hypoglycemia or hyperglycemia.
How to manage the interaction:
There may be a possibility of interaction between Glybovin 2.5 mg Tablet 10's and Enoxacin, but it can be taken if prescribed by a doctor. If you notice any symptoms like headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat, increased thirst, increased hunger, and increased urination. Do not stop using any medications without talking to a doctor.
When Glybovin 2.5 mg Tablet 10's is taken with Enoxacin, it may affect the blood glucose levels which may leads to hypoglycemia or hyperglycemia.
How to manage the interaction:
There may be a possibility of interaction between Glybovin 2.5 mg Tablet 10's and Enoxacin, but it can be taken if prescribed by a doctor. If you notice any symptoms like headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat, increased thirst, increased hunger, and increased urination. Do not stop using any medications without talking to a doctor.
GlibenclamideSparfloxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Sparfloxacin can sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with sparfloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Do not discontinue the medications without consulting a doctor.
Co-administration of Sparfloxacin can sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with sparfloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Do not discontinue the medications without consulting a doctor.
GlibenclamideCinoxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Glybovin 2.5 mg Tablet 10's with Cinoxacin can sometimes affect blood glucose levels. Both hyperglycemia (high blood glucose) and, less frequently, hypoglycemia (low blood glucose) have been reported.
How to manage the interaction:
Co-administration of Glybovin 2.5 mg Tablet 10's with Cinoxacin can possibly result in an interaction, but it can be taken if a doctor has advised it. It's important to keep an eye on your urination and if you notice any changes, let your doctor know. If you experience any of these symptoms - high or low blood sugar, severe infections, headaches, dizziness, confusion, or feeling shaky, make sure to call a doctor right away. Do not discontinue any medications without consulting a doctor.
Co-administration of Glybovin 2.5 mg Tablet 10's with Cinoxacin can sometimes affect blood glucose levels. Both hyperglycemia (high blood glucose) and, less frequently, hypoglycemia (low blood glucose) have been reported.
How to manage the interaction:
Co-administration of Glybovin 2.5 mg Tablet 10's with Cinoxacin can possibly result in an interaction, but it can be taken if a doctor has advised it. It's important to keep an eye on your urination and if you notice any changes, let your doctor know. If you experience any of these symptoms - high or low blood sugar, severe infections, headaches, dizziness, confusion, or feeling shaky, make sure to call a doctor right away. Do not discontinue any medications without consulting a doctor.
GlibenclamideNorfloxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Norfloxacin with Glybovin 2.5 mg Tablet 10's may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Norfloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without consulting a doctor.
Co-administration of Norfloxacin with Glybovin 2.5 mg Tablet 10's may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Norfloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without consulting a doctor.
GlibenclamideCiprofloxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Glybovin 2.5 mg Tablet 10's with Ciprofloxacin may affect blood glucose levels leading to high blood glucose levels, and less frequently low blood glucose levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Ciprofloxacin if prescribed by the doctor. Consult the doctor if you experience symptoms such as headache, dizziness, drowsiness, nervousness, confusion, tremor(shaking), nausea, hunger, weakness, sweating, rapid heartbeat, increased thirst, increased hunger, and increased urination. Do not discontinue the medications without consulting a doctor.
Co-administration of Glybovin 2.5 mg Tablet 10's with Ciprofloxacin may affect blood glucose levels leading to high blood glucose levels, and less frequently low blood glucose levels.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Ciprofloxacin if prescribed by the doctor. Consult the doctor if you experience symptoms such as headache, dizziness, drowsiness, nervousness, confusion, tremor(shaking), nausea, hunger, weakness, sweating, rapid heartbeat, increased thirst, increased hunger, and increased urination. Do not discontinue the medications without consulting a doctor.
GlibenclamideOfloxacin
Severe
How does the drug interact with Glybovin 2.5 mg Tablet 10's:
Co-administration of Ofloxacin with Glybovin 2.5 mg Tablet 10's can sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Ofloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
Co-administration of Ofloxacin with Glybovin 2.5 mg Tablet 10's can sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Glybovin 2.5 mg Tablet 10's can be taken with Ofloxacin if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat or symptoms of high blood sugar such as increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
GLIBENCLAMIDE-2.5MGComplications and ill-defined descriptions of heart disease
Severe
GLIBENCLAMIDE-2.5MGOther diseases of liver
Severe
Drug-Diseases Interactions
Login/Sign Up
GLIBENCLAMIDE-2.5MGComplications and ill-defined descriptions of heart disease
Severe
How does the disease interact with Glybovin 2.5 mg Tablet 10's:
Compared to diet alone or diet plus insulin, the use of oral hypoglycemic medicines may be linked to a higher risk of cardiovascular mortality. The University Group Diabetes Programme (UGDP) project, a lengthy prospective clinical trial created to assess the efficacy of glucose-lowering medications in preventing or postponing vascular problems in individuals with non-insulin-dependent diabetes, is the basis for this warning. Since the cardiovascular death rate was almost 2.5 times higher in patients receiving diet plus a fixed dosage of either tolbutamide (a sulfonylurea) or phenformin (a biguanide) for 5 to 8 years, both of these therapies were stopped in the research. Despite disagreements surrounding how to interpret these findings, physicians and patients should be aware of the possibility
How to manage the interaction:
Oral hypoglycemic agents may be associated with an increased risk of heart problems. Let the doctor know if you have heart problems.
Compared to diet alone or diet plus insulin, the use of oral hypoglycemic medicines may be linked to a higher risk of cardiovascular mortality. The University Group Diabetes Programme (UGDP) project, a lengthy prospective clinical trial created to assess the efficacy of glucose-lowering medications in preventing or postponing vascular problems in individuals with non-insulin-dependent diabetes, is the basis for this warning. Since the cardiovascular death rate was almost 2.5 times higher in patients receiving diet plus a fixed dosage of either tolbutamide (a sulfonylurea) or phenformin (a biguanide) for 5 to 8 years, both of these therapies were stopped in the research. Despite disagreements surrounding how to interpret these findings, physicians and patients should be aware of the possibility
How to manage the interaction:
Oral hypoglycemic agents may be associated with an increased risk of heart problems. Let the doctor know if you have heart problems.
GLIBENCLAMIDE-2.5MGOther diseases of liver
Severe
How does the disease interact with Glybovin 2.5 mg Tablet 10's:
sulfonylureas are metabolized in the liver, and their metabolites (some with pharmacologic activity) are excreted in the urine and feces. Patients with impaired liver and/or renal function treated with sulfonylureas may be exposed to higher serum drug concentrations, which can increase the potential for severe hypoglycemic episodes induced by these agents. In the presence of hepatic impairment, gluconeogenic capacity may also be diminished, further compounding the risk. Therapy with sulfonylureas should be administered cautiously in patients with liver and/or renal disease. Reduced dosages and longer intervals between dosage adjustments may be required. Hypoglycemia, if it occurs during treatment, may be prolonged in these patients because of slowed metabolism and/or excretion of the drugs.
How to manage the interaction:
Therapy with sulfonylureas should be administered cautiously in patients with liver disease.
sulfonylureas are metabolized in the liver, and their metabolites (some with pharmacologic activity) are excreted in the urine and feces. Patients with impaired liver and/or renal function treated with sulfonylureas may be exposed to higher serum drug concentrations, which can increase the potential for severe hypoglycemic episodes induced by these agents. In the presence of hepatic impairment, gluconeogenic capacity may also be diminished, further compounding the risk. Therapy with sulfonylureas should be administered cautiously in patients with liver and/or renal disease. Reduced dosages and longer intervals between dosage adjustments may be required. Hypoglycemia, if it occurs during treatment, may be prolonged in these patients because of slowed metabolism and/or excretion of the drugs.
How to manage the interaction:
Therapy with sulfonylureas should be administered cautiously in patients with liver disease.
GLIBENCLAMIDE-2.5MGOther disorders of pancreatic internal secretion
Moderate
How does the disease interact with Glybovin 2.5 mg Tablet 10's:
When receiving therapy with insulin and/or oral hypoglycemic medications, hypoglycemia can frequently happen. Patients who may be particularly vulnerable to the onset of hypoglycemic episodes while taking these medications include those who are weak or malnourished, those who have faulty counterregulatory mechanisms (such as autonomic neuropathy and adrenal or pituitary insufficiency), and those who are taking beta-adrenergic blocking medications.
How to manage the interaction:
During treatment with oral hypoglycemic agents low blood sugar may commonly occur. Caution is advised in patients who may be particularly susceptible to the development of hypoglycemic episodes, including those who are weak or malnourished, those with autonomic neuropathy and adrenal or pituitary insufficiency, and those receiving beta-adrenergic blocking agents.
When receiving therapy with insulin and/or oral hypoglycemic medications, hypoglycemia can frequently happen. Patients who may be particularly vulnerable to the onset of hypoglycemic episodes while taking these medications include those who are weak or malnourished, those who have faulty counterregulatory mechanisms (such as autonomic neuropathy and adrenal or pituitary insufficiency), and those who are taking beta-adrenergic blocking medications.
How to manage the interaction:
During treatment with oral hypoglycemic agents low blood sugar may commonly occur. Caution is advised in patients who may be particularly susceptible to the development of hypoglycemic episodes, including those who are weak or malnourished, those with autonomic neuropathy and adrenal or pituitary insufficiency, and those receiving beta-adrenergic blocking agents.
GLIBENCLAMIDE-2.5MGAnaemia due to enzyme disorders
Moderate
How does the disease interact with Glybovin 2.5 mg Tablet 10's:
In people who lack the enzyme glucose 6-phosphate dehydrogenase (G6PD), sulfonylureas can lead to hemolytic anaemia. Patients with G6PD deficiency should use these medications with caution and may want to look for non-sulfonylurea alternatives. Following the launch of these medications, reports of hemolytic anaemia in people who had no known G6PD deficiency were made.
How to manage the interaction:
Therapy should be used with caution in patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency and the use of a non-sulfonylurea alternative should be considered as sulfonylureas may cause hemolytic anemia in patients with G6PD deficiency.
In people who lack the enzyme glucose 6-phosphate dehydrogenase (G6PD), sulfonylureas can lead to hemolytic anaemia. Patients with G6PD deficiency should use these medications with caution and may want to look for non-sulfonylurea alternatives. Following the launch of these medications, reports of hemolytic anaemia in people who had no known G6PD deficiency were made.
How to manage the interaction:
Therapy should be used with caution in patients with glucose 6-phosphate dehydrogenase (G6PD) deficiency and the use of a non-sulfonylurea alternative should be considered as sulfonylureas may cause hemolytic anemia in patients with G6PD deficiency.
GLIBENCLAMIDE-2.5MGOther disorders of fluid, electrolyte and acid-base balance
Moderate
How does the disease interact with Glybovin 2.5 mg Tablet 10's:
In individuals who are taking other drugs, have medical problems that are known to induce hyponatremia, or have conditions that promote the release of antidiuretic hormone, treatment with sulfonylureas may result in hyponatremia. Certain sulfonylureas have been linked to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion, and these medications may enhance the peripheral (antidiuretic) action of ADH or increase ADH release. Patients with hyponatremia or those who are more likely to develop it, such as the elderly, those on diuretics, or those who are volume-depleted, should be treated with caution.
How to manage the interaction:
Treatment with sulfonylureas may cause hyponatremia (low sodium level), in patients who are on other medications or have medical conditions known to cause hyponatremia or increase release of antidiuretic hormone. Caution should be used when treating patients with hyponatremia or at greater risk of developing hyponatremia such as elderly patients, patients taking diuretics or those who are volume-depleted.
In individuals who are taking other drugs, have medical problems that are known to induce hyponatremia, or have conditions that promote the release of antidiuretic hormone, treatment with sulfonylureas may result in hyponatremia. Certain sulfonylureas have been linked to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion, and these medications may enhance the peripheral (antidiuretic) action of ADH or increase ADH release. Patients with hyponatremia or those who are more likely to develop it, such as the elderly, those on diuretics, or those who are volume-depleted, should be treated with caution.
How to manage the interaction:
Treatment with sulfonylureas may cause hyponatremia (low sodium level), in patients who are on other medications or have medical conditions known to cause hyponatremia or increase release of antidiuretic hormone. Caution should be used when treating patients with hyponatremia or at greater risk of developing hyponatremia such as elderly patients, patients taking diuretics or those who are volume-depleted.
Glybovin 2.5 mg Tablet 10's Substitute
SEMI DAONIL 2.5MG TABLET
₹0.63per tabletSEMI EUGLUCON 2.5 MG TABLET
₹4.81per tablet
